<table id="id_a20978b1-6ddd-416f-9b50-434aab45a3d9" width="323.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_32a285a5-4e96-42a3-a6c8-e74374443c82">Table 2 Pharmacokinetic Parameters of Voriconazole in Patients at Risk for Aspergillosis</caption>
<col align="left" width="26.6%"></col>
<col align="center" width="33.4%"></col>
<col align="center" width="39.9%"></col>
<thead>
<tr id="id_27d99804-f1a0-4e88-b794-56878ef4b0ba">
<td align="left" stylecode="Botrule Rrule" valign="top"></td>
<td align="left" stylecode="Rrule" valign="top">200 mg Oral Q12h<br/>(n=9)</td>
<td align="left" stylecode="Botrule" valign="top">300 mg Oral Q12h<br/>(n=9)</td>
</tr>
</thead>
<tbody>
<tr id="id_cafcc57d-276c-4bb1-8a6d-0b2638f05224">
<td align="left" stylecode="Toprule Botrule" valign="top">AUC<sub>τ</sub>
<footnote id="id-2b07dde8-7300-4337-a3c2-eea1bcc57fa2">Geometric mean values on Day 14 of multiple dosing in 2 cohorts of patients</footnote> (µg∙h/mL )<br/>(CV%)</td>
<td align="left" stylecode="Botrule" valign="top">20.31<br/>(69%)</td>
<td align="left" stylecode="Botrule" valign="top">36.51<br/>(45%)</td>
</tr>
<tr id="id_d6679c9c-8baa-426f-b1ac-5d1a27401ec1">
<td align="left" stylecode="Botrule" valign="top">C<sub>max</sub>
<footnoteref idref="id-2b07dde8-7300-4337-a3c2-eea1bcc57fa2"></footnoteref> (µg/mL)<br/> (CV%) </td>
<td align="left" stylecode="Botrule" valign="top">3.00<br/>(51%)</td>
<td align="left" stylecode="Botrule" valign="top">4.66<br/>(35%)</td>
</tr>
</tbody>
</table>